PULMONARY UPTAKE OF SESTAMIBI ON EARLY POSTSTRESS IMAGES - ANGIOGRAPHIC RELATIONSHIPS, INCIDENCE AND KINETICS

被引:23
作者
HURWITZ, GA
FOX, SP
DRIEDGER, AA
WILLEMS, C
POWE, JE
机构
[1] Department of Diagnostic Radiology/Nuclear Medicine, Department of Medicine, University of Western Ontario, Department of Nuclear Medicine, Victoria Hospital, London, ON
关键词
D O I
10.1097/00006231-199301000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Early post-stress imaging with Tc-99m-sestamibi has the potential to reveal ancillary markers of severe coronary artery disease. Lung/myocardial ratios of sestamibi were assessed after pharmacologic, exercise or combined stress, and these were compared with historical controls who were stressed similarly, but imaged with Tl-201. Forty initial patients had planar imaging and correlating angiograms; pulmonary uptake for sestamibi related to severe coronary artery stenoses when measured on immediate images, started at 4 min post-stress (P = 0.04), but had a poor relationship to angiographic findings when measured on delayed clinical images. Of 180 subsequent studies, increased pulmonary uptake of sestamibi was seen more frequently (incidence = 34%) in those with abnormal tomograms compared to those with normal tomograms (incidence = 13%, P < 0.01), but appeared less frequently than on abnormal Tl-201 studies (incidence = 60%). With sequential imaging for 5 min after injection, pulmonary uptake showed a greater fall with time on sestamibi studies than on matched Tl-201 studies. No consistent differences were seen among the stress modalities. As an ancillary sign of haemodynamically severe disease, increased pulmonary uptake can be seen after various stress modalities, but may be more difficult to apply with sestamibi than with thallium imaging.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 17 条
[1]  
Wackers F., Berman D.S., Maddahi J., Et al., Technetium- 99m hexakis 2-methoxyisobutylisonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging, J Nucl Med, 30, pp. 301-311, (1989)
[2]  
Maisey M.M., Mistry R., Sowton E., Planar imaging techniques used with technetium-99m sestamibi to evaluate chronic myocardial ischemia, Am J Cardiol, 66, (1990)
[3]  
Leppo J.A., Depuey E.G., Johnson L.L., A review of cardiac imaging with sestamibi and teboroxime, J Nud Med, 32, pp. 2012-2022, (1991)
[4]  
Hurwitz G.A., Powe J.E., Driedger A.A., Finnie K., Laurin R., Macdonald C., Dipyridamole combined with symptom- limited exercise for myocardial perfusion scintigraphy: Image characteristics and clinical role, Eur J Nud Med, 17, pp. 61-68, (1990)
[5]  
Hurwitz G.A., O'donoghue J.P., Powe J.E., Gravelle D.R., Macdonald A.C., Finnie K., Pulmonary thallium-201 uptake following dipyridamole-exercise combination compared with single modality stress-testing, Am J Cardiol, 69, pp. 320-326, (1992)
[6]  
Dae M., Canhasi B., Botvinick E., Et al., The etiology and implications of dense cavitary 'photopenia' on myocardial perfusion scintigraphy, Invest Radiol, 20, pp. 388-392, (1985)
[7]  
Depuey E.G., Exercise supplementation of dipyridamole for myocardial perfusion imaging, J Nud Med, 32, pp. 1564-1568, (1991)
[8]  
Tartagni F., Dondi M., Limonetti P., Franchi R., Maiello L., Monetti N., Magnani B., Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: Comparison with thallium-201 stress-rest study, J Mucl Med, 32, pp. 369-376, (1991)
[9]  
Iskandrian A.S., Dipyridamole sestamibi myocardial imaging, Am J Cardiol, 68, pp. 674-675, (1991)
[10]  
Boucher C.A., Zir L.M., Beller G.A., Okada R.D., McKusick K.A., Strauss H.W., Post G.M., Increased lung uptake of thallium-201 during exercise myocardial imaging: Clinical, hemodynamic and angiographic implications in patients with coronary artery disease, Am J Cardiol, 46, pp. 189-196, (1980)